Stay updated with breaking news from Study Evaluating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SPRING HOUSE, PENNSYLVANIA, May 31, 2023 - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 3b COSMOS clinical trial showing that treatment... | May 31, 2023
/PRNewswire/ -- The American Society of Clinical Oncology (ASCO) recently announced the selected abstracts for the prestigious ASCO 2023 Annual Meeting. Four...
Axsome Therapeutics reported a 13% year-over-year increase in prescriptions for Sunosi for adults with excessive daytime sleepiness.
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data, showing that initiation of TREMFYA® (guselkumab) was...
During its fourth-quarter and full-year 2022 earnings call, Axsome Therapeutics provided business updates on Sunosi and AXS-12.